Pilot evaluates how AI-enabled note creation can reduce administrative burden and enhance home-based clinical interactions.
LONDON, UNITED KINGDOM, January 7, 2026 /EINPresswire.com/ — Sciensus, a European leader in integrated end-to-end commercial services, today announced the launch of a new pilot evaluating how Dragon Copilot, with its AI capabilities, can be used within Sciensus’ home-based care workflows. The project explores whether AI can reduce administrative workload, create more time for meaningful patient interactions and capture data generated outside tightly controlled clinical environments.
Sciensus is trialling the Dragon Copilot mobile app for ambient speech capture, working alongside its existing Intouch mobile app and patient-engagement platform built on Microsoft Dynamics 365. The trial is part of the Sciensus initiative ‘CareTranscribe’ and focuses specifically on evaluating AI-generated note accuracy and documentation support. It will run initially across England and Scotland with patients receiving homecare support. During the pilot, Sciensus’ clinical nurse specialists working in the community will use Dragon Copilot to securely capture patient consultation audio and automatically transform their interactions into detailed notes and structured summaries.
“Our nurses are at the heart of patient care, and anything that gives them more time with their patients is a meaningful step forward. We continuously strive to improve the experience and the personalisation of patient care and feeling heard by your nurse team through natural, flowing conversations is a substantial benefit for patient-nurse interactions,” said Christian Tucat, CEO at Sciensus. “By working with Microsoft, we are leveraging responsible-AI technology to support our pharmaceutical partners in capturing aggregated and anonymised real-world data that can drive continued healthcare improvements. It’s a purposeful combination of human compassion and intelligent technology – all in service of better patient care.”
The pilot supports the ambitions of the NHS 10-Year Plan by reducing administrative burden and freeing clinicians to spend more time with patients whilst maintaining high-quality, clinical documentation. During the pilot, clinical conversations will be captured ambiently during home visits and transcribed for nurses to review as a supportive input when completing Sciensus’ clinical evaluation forms. This initial phase is deliberately focused on validating transcription accuracy and quality, understanding patient comfort and consent around recording, and assessing nurse usability and fit within existing clinical workflows.
Jacob West, Managing Director, Healthcare & Life Sciences, Microsoft UK, said: “Microsoft Dragon Copilot is helping transform care delivery by taking away the administrative burden that often pulls clinicians away from patients. By embedding seamlessly into existing workflows, it frees time for meaningful interactions, supporting clinician wellbeing and improving patient experiences. Seeing organisations like Sciensus embrace this technology is a powerful step towards delivering a better experience for both staff and patients.”
A responsible, governance-led approach
The pilot is being delivered in alignment with NHS information governance and UK and EU legal requirements, including patient consent, clear data-handling standards and strict anonymisation processes. The pilot is delivered in accordance with relevant Class I medical-device requirements. In future phases, Sciensus aims to explore additional capabilities, such as using Azure Machine Learning models to identify potential adverse events or adherence concerns. Any future development will be subject to clinical validation, governance review and regulatory requirements.
Unlocking real-world insights from home-based care
As the UK’s largest provider of home-based specialty clinical services, Sciensus clinicians engage in millions of patient conversations each year. These conversations offer a unique window into the realities of treatment at home. As part of our overall commitment to continuously improving patient experiences, Sciensus is broadly exploring how these insights could shape future therapies, enhance patient support and improve care across complex conditions.
About Sciensus
Sciensus is a European leader in integrated end-to-end commercial services, supporting patients, health systems, providers and biopharma companies. We offer distribution services, clinical care at home, digital solutions and patient insights to accelerate access to medicines and maximise product launches from clinical to full commercialisation. With over 30 years’ experience navigating the complex European healthcare ecosystem, Sciensus helps bring the right medicine to the right patients – faster. https://www.sciensus.com/
Danielle Whitney
Sciensus
marketing@sciensus.com
Visit us on social media:
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
